Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

2025 Young Urologist of the Year Award Winners

Established by the 2012-2013 AUA Young Urologists Committee (YUC) Chair, Dr. Michael C. Ost, the Young Urologist of the Year Award is presented annually to select early-career AUA members in recognition of their efforts and commitment to advancing the development of fellow young urologists. The following members were selected by their colleagues who serve on the Young Urologists Committee and endorsed by their respective Section/Society to receive this special honor for 2025.

Robert Caleb Kovell, MD

Robert Caleb Kovell, MD

University of Pennsylvania

Mid-Atlantic Section

Dr. Robert Caleb Kovell has made significant contributions to medical education and urology, particularly at the University of Pennsylvania, where he serves as Program Director for the Urology Residency Program. His leadership has been instrumental in shaping the next generation of urologists through innovative curriculum development and mentorship. His dedication to resident education earned him the Departmental Excellence in Teaching Award (2021) and the Resident Advocate Award (2022 and 2023).  He has been instrumental in leading a strong residency program focusing on community development, scholarship, and culture creation. As program director, he leads international trips to Panama and Liberia, supports local free clinics in Puentes and the Center for Surgical Health, and works tirelessly to ensure every urology resident graduates with a well-rounded view of all aspects of patient care.  Outside the hospital, he is a dedicated husband and father to three young children. 

Jaimie A. Cavallo, MD, MPHS

Jaime A. Cavallo, MD, MPHS

Yale University

New England Section

Dr. Cavallo is an Assistant Professor of Urology, Director of Male Genitourinary Reconstructive Surgery, and Vice Chair of Quality and Safety at Yale University. She is widely recognized by her peers and the New England Section Board of Directors for her passionate leadership of the Section’s DEI Committee, as well as for launching the Section’s FUTURE in Urology Program in 2024.

Dr. Cavallo completed the Yale School of Medicine DEI Leadership Program and the Yale Emerging Leaders Executive Program. She has played an instrumental role in numerous DEI-focused initiatives at her institution. Drawing from this experience, she successfully led the recruitment, fundraising, and planning of the FUTURE program, which mentored 10 underrepresented minority medical students during the Section’s 2024 Annual Meeting. With plans to build upon this success, Dr. Cavallo is committed to expanding opportunities for diverse medical students in the field of urology.

John P. Sfakianos, MD

John P. Sfakianos, MD

Icahn School of Medicine at Mount Sinai

New York Section

John Sfakianos, MD, is an Associate Professor of Urology and Urologic Oncology at the Icahn School of Medicine at Mount Sinai. His clinical focus includes treating patients with urothelial cancers of the upper urinary tract and bladder. He offers patients treatment options through his expertise in treating urologic conditions using open, laparoscopic and robotic techniques. He performs both robotic and open nephroureterectomies, partial cystectomies and cystectomies and forms urinary diversions including ileal conduits, continent catherizable pouches, and continent urinary diversions (ileal neobladder). His clinical interests and skills also include surgical treatment of patients with kidney, prostate, testicular and penile cancers.

Dr. Sfakianos is a firm believer in a multidisciplinary approach to cancer care. He works closely with his colleagues in medical oncology and radiation oncology to provide a customized, integrated and innovative approach to treatment of patients with urologic cancers. His research focuses on the approach to treating urothelial and prostate cancers in personalized medicine, including genomic analyses of tumors, to predict risk and response to therapy. In laboratory research, he is using mouse models in prostate and bladder cancer to identify novel treatments. Dr. Sfakianos has published over 20 research articles in peer-reviewed publications, written book chapters on urothelial carcinoma and is a reviewer for the Journal of Urology and Urologic Oncology.

Dr. Sfakianos received his medical degree from the School of Medicine and Biomedical Sciences at Buffalo and completed his internship and residency at the State University of New York at Downstate Medical Center. He went on to complete a fellowship in Urologic Oncology accredited by the Society of Urologic Oncology at the Memorial Sloan Kettering Cancer Center.

Kyle Richards, MD, FACS

Kyle Richards, MD, FACS

University of Wisconsin-Madison

North Central Section

Kyle A. Richards is a practicing urologic oncologist at the University of Wisconsin with a clinical and research focus on bladder cancer. When he finished his training in 2014, he was hired at UW-Madison and took over as Chief of Urology at the William S. Middleton Memorial Veterans Hospital in Madison, WI. He was Chief of Urology for 9+ years before stepping down in January of 2024 to focus on his academic bladder cancer program as well as co-lead the urology residency program. 

During his nearly 10 years on faculty at UW-Madison, he has built a destination bladder cancer program that he now leads having performed nearly 600 cystectomies and opening numerous clinical trials.  He serves as a panelist for the National Comprehensive Cancer Network Guidelines for bladder cancer and is a reviewer for the Bladder Cancer Advocacy Network Patient-Centered Clinical Young Investigator Award. 

Dr. Richards is a graduate of the prestigious AUA Leadership program and past chair of the AUA Young Urologist Committee.  He also serves the Urology Care Foundation as current chair of the Technology and Publications Committee.  Lastly, Dr. Richards is a leader in health policy having served as the AUA advisor to the RUC from 2015-2022 and ascended to the AUA RUC member position in 2022.

Scott Wiener, MD

Scott Wiener, MD

SUNY Upstate Medical University

Northeastern Section

Dr. Scott Wiener is an Associate Professor of Urology at SUNY Upstate Medical University, where he currently serves as the Chief of Endourology, Departmental Quality Officer and Chief of Service at Community General Hospital. Dr. Wiener completed his Residency at the University of Connecticut and a Fellowship in Endourology and Laparoscopy at the University of California San Francisco. His clinical and research interests include nephrolithiasis and benign prostatic hyperplasia. He is the founding member of the Prostate Enucleation Collaborative, a research and advocacy group comprised of young Endourologists across the United States and Canada. Areas of active research include the use of stone targeting microbubbles for the treatment of nephrolithiasis and quality improvement in HoLEP.

Casey Kowalik, MD, FACS

Casey Kowalik, MD, FACS

University of Kansas Medical Center

South Central Section

Dr. Casey Kowalik is an Associate Professor at the University of Kansas, where she is also the Residency Program Director.  Dr. Kowalik graduated residency from Lahey Hospital & Medical Center and completed an Urogynecology and Reconstructive Pelvic Surgery fellowship at Vanderbilt University. She is active in SUFU, South Central Section, and the Urology Care Foundation and was co-chair of the 2025 Society of Academic Urology Annual Winter meeting.  Her greatest passion is improving resident education.  She has led the charge to create a rural track program at KU, which recently matched its first resident. Her current research focuses on medical school assessment of surgical skills.

Christoher Keel, DO, FACS

Christopher Keel, DO, FACS

University of South Alabama Health

Southeastern Section

Christopher E. Keel, DO, FACS, is an Associate Professor and Chair of the Department of Urology at the University of South Alabama.  He completed his urology training at Tulane University, where he developed a deep passion for resident education and improving access to care for underserved populations. During his time at Tulane, Dr. Keel was honored with the SESAUA Montague Boyd Prize and was recognized by both residents and attending physicians for his leadership skills, culminating in being named Physician of the Year by Interim Louisiana Public Health System.  Nationally, Dr. Keel holds important leadership roles. He serves on the Board of the Southeast Section of the American Urological Association (AUA) and the Society of Academic Urologists. He is particularly passionate about addressing the urology workforce shortage, and his current efforts with the AUA and SAU are focused on tackling this challenge through a Urology Workforce Initiative he is leading.  Clinically, Dr. Keel is known for his expertise in robotic surgery and enjoys integrating new technology into patient care.  He is an avid pilot and an FAA designated Aeromedical Examiner.

Ekene Enemchukwu, MD, MPH, FACS, URPS

Ekene Enemchukwu, MD, MPH, FACS, URPS

Standford Medicine

Western Section

Dr. Enemchukwu is the Director of Urology at the Stanford Pelvic Health Center and an Associate Professor of Urology at Stanford School of Medicine. She specializes in URPS and is dedicated to advancing health equity in pelvic health care. A leader in treating pelvic floor disorders such as pelvic organ prolapse, urinary incontinence, overactive bladder, and urethral stricture disease, Dr. Enemchukwu is skilled in both minimally invasive and open surgical techniques.

Dr. Enemchukwu completed her undergraduate studies at Duke University and earned her MD and MPH at the University of North Carolina. She trained in General Surgery and Urology at Vanderbilt University Medical Center, followed by a fellowship in Female Pelvic Medicine & Reconstructive Surgery at NYU Langone Medical Center. An NIH-funded health services researcher, she focuses on improving access to care, reducing barriers to care and fostering shared decision-making for conditions such as OAB, urinary incontinence and genitourinary syndrome of menopause. Dr. Enemchukwu is an editor for the Journal of Urology and serves on the editorial board of Neurourology and Urodynamics. She has authored numerous publications and regularly lectures and participates in media interviews on OAB.

Dr. Enemchukwu also plays a vital role in mentoring and training the next generation of physicians. She is passionate about preparing future leaders to navigate the evolving healthcare landscape, particularly through a lens of integrity, collaboration, and compassion. Her advocacy extends to empowering women locally, nationally, and internationally through mentorship. She aspires to be known for her commitment to leading with empathy and excellence.

LTC Sean Q. Kern, MC, USA

LTC Sean Q. Kern, MC, USA

Murtha Cancer Center at the Uniformed Services University (USU) and Walter Reed National Military Medical Center

Society of Government Service Urologists

LTC Sean Kern is a urologic oncologist and Associate Professor of Surgery in the Murtha Cancer Center at the Uniformed Services University (USU) and Walter Reed National Military Medical Center in Bethesda, MD.  In this role, he created and serves as the founding Director of the Testicular cancer Enterprise for Survivorship, Treatment, and Investigational Sciences “TESTIS” Program at the Murtha Cancer Center at USU.  The TESTIS Center serves as the central research, treatment, and survivorship hub for the Department of Defense and has improved treatment, surveillance, and survivorship for the most-diagnosed malignancy among Active Duty servicemembers.  The TESTIS Center has been recognized by the Testicular Cancer Awareness Foundation as a Center of Excellence.  He serves as Principal Investigator on numerous DoD-wide studies in both testicular and prostate cancer.  Additionally, Dr. Kern serves as the Program Director of the National Capital Consortium Walter Reed Urology Residency Program, which is the oldest and largest urology program in the Department of Defense.  Dr. Kern runs the annual mock oral boards at the Society of Government Services Urologists meeting, which has prepared dozens of military urologists for the oral board examinations. He served his residency at the Tripler Army Medical Center and completed his SUO fellowship at Indiana University.